Therapic effect of lauromacrogol sclerotherapy on infantile hemangioma
10.3760/cma.j.issn.1671-0290.2013.05.012
- VernacularTitle:聚桂醇硬化剂治疗婴幼儿皮肤血管瘤的临床疗效
- Author:
Shan JIANG
;
Ling LU
;
Yingzi HU
;
Hui LI
;
Hong LIANG
- Publication Type:Journal Article
- Keywords:
Hemangioma;
Sclerotherapy;
Lauromacrogol
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2013;19(5):359-361
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of intralesional lauromacrogol therapy on infantile hemangioma.Methods 30 cases all received intralesional injection of lauromacrogol.The changes of tumor size,texture and color were monitored and recorded.The adverse effects after medication were observed and managed accordingly.The adverse effects after medication were observed.The times of treatment were determined according to degree of reduction of tumor volume.To assess the efficacy,a 4 scales system was adopted.Results All patients had completed the treatment and followup.The overall response was scale Ⅰ in 2 cases (6.7 %),scale Ⅱ efficacy in 4 patients (13.3 %),scale Ⅲ efficacy in 5 cases (16.7 %) and scale Ⅳ in 19 cases (63.3 %).The smaller the tumor,the fewer the times of treatment,and the better the results.The effects of treatment were better if patient could be treated by intralesional lauromacrogol therapy in early stage.No severe adverse effects were observed during 6 months of follow-up.Conclusions Intralesional injection of lauromacrogol sclerotherapy is a safe and effective way to treat infantile hemangioma.